Format

Send to

Choose Destination
Discov Med. 2010 May;9(48):399-403.

Reengineered AAV vectors: old dog, new tricks.

Author information

1
Gene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. aravind_asokan@med.unc.edu

Abstract

Adeno-associated viral (AAV) vectors have emerged in recent years as powerful tools for therapeutic gene transfer. Successes in clinical trials and the discovery of several hundreds of naturally occurring AAV isolates have triggered efforts to understand and manipulate this deceptively simple parvovirus for a myriad of gene therapy applications. Exciting breakthroughs based on directed evolution of novel tissue-specific variants from combinatorial AAV libraries have been reported. Recent approaches driven by the availability of structural information have yielded a new generation of reengineered AAV vectors.

PMID:
20515607
PMCID:
PMC2900186
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center